Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

12345678910

GSK wins China approval for Blenrep for refractory multiple myeloma

20th Apr 2026 08:47

(Alliance News) - GSK PLC on Monday said the National Medical Products Administration of China has approved Blenrep in combination with bortezomib and dexamethasone in the treatment of adults with relapsed or refractory multiple myeloma. Read More

LONDON BRIEFING: Kainos guides revenue beat; Evoke in takeover talks

20th Apr 2026 07:56

(Alliance News) - Plus500 expects 2026 earnings to beat current expectations, Advanced Medical Solutions and Evoke separately confirm takeover talks and Auction Technology says its long-standing chief executive officer will step down soon. Read More

LONDON MARKET CLOSE: Traders weigh war deadlock; luxury woes hit Paris

15th Apr 2026 17:02

(Alliance News) - The FTSE 100 fell on Wednesday as investors awaited a hoped for resumption in peace talks between the US and Iran. Read More

GSK completes purchase of Canada's 35Pharma for USD950 million

15th Apr 2026 10:33

(Alliance News) - GSK PLC on Wednesday said it has completed the acquisition of Canada-based clinical stage biopharmaceutical firm 35Pharma Inc for USD950 million in cash. Read More

LONDON BROKER RATINGS: Bernstein cuts Wizz Air and easyJet

13th Apr 2026 09:39

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

GSK posts encouraging data for endometrial and ovarian cancer drug

13th Apr 2026 07:00

(Alliance News) - GSK PLC on Sunday reported positive data for its cancer therapy candidate mocertatug rezetecan. Read More

LONDON MARKET CLOSE: Oil creeps higher amid fragile US-Iran ceasefire

9th Apr 2026 17:07

(Alliance News) - The FTSE 100 nursed modest losses on Thursday as doubts grew over the strength and sustainability of the US-Iran ceasefire. Read More

China approves GSK's Exdensur for treating chronic rhinosinusitis

8th Apr 2026 08:59

(Alliance News) - GSK PLC on Wednesday said its Exdensur drug, has been approved in China as an add-on therapy for the treatment of chronic rhinosinusitis with nasal polyps. Read More

LONDON BRIEFING: Shell trims output view but refining margins climb

8th Apr 2026 07:50

(Alliance News) - Shell says the Middle East conflict hit output in its Integrated Gas arm, though it sees "significantly higher" trading and optimisation results. GSK announces a drug approval in China, while Close Brothers believes the cost of the final motor finance redress can be "comfortably absorbed". Read More

UK dividends calendar - next 7 days

2nd Apr 2026 12:07

Read More

Shionogi completes purchase of Pfizer stake in GSK's ViiV Healthcare

1st Apr 2026 09:18

(Alliance News) - GSK PLC and Shionogi & Co Ltd on Wednesday said the replacement of Pfizer Inc's stake in the ViiV Healthcare Ltd joint venture with an equal investment by Shionogi has been completed. Read More

LONDON MARKET OPEN: FTSE 100 higher as oil, mining stocks climb

30th Mar 2026 09:10

(Alliance News) - Stock prices in London opened mixed on Monday, ahead of UK mortgage approvals data and as the US and Iran's contrasting statements on the ongoing conflict continue. Read More

GSK shares rise on regulatory momentum for two drugs in China

30th Mar 2026 09:05

(Alliance News) - GSK PLC on Monday reported regulatory momentum in China for its drugs Exdensur and bepirovirsen. Read More

European Medicine Agency to review GSK's chronic hepatitis B treatment

27th Mar 2026 08:38

(Alliance News) - GSK PLC on Friday said the European Medicines Agency has accepted for review its investigational chronic hepatitis B treatment, bepirovirsen. Read More

LONDON BRIEFING: UK retail sales fall; GSK drug accepted for review

27th Mar 2026 07:56

(Alliance News) - UK retail sales fell in the month of February but by less than expected, while GSK and AstraZeneca hailed positive clinical and regulatory progress. Herald Investment Trust said it will proceed with a backstop tender offer for up to 100% of shares if no agreement is reached with Saba. Read More

WINNERS & LOSERS: Next climbs; Ceres jumps on Centrica deal

26th Mar 2026 10:46

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday. Read More

LONDON MARKET CLOSE: FTSE 100 climbs on Middle East peace deal hopes

25th Mar 2026 16:59

(Alliance News) - Stocks rallied on Wednesday, and oil prices cooled, on hopes for an end to the conflict in the Middle East despite Iran reportedly rejecting a peace plan proposed by the US. Read More

DIRECTOR DEALINGS: GSK, Smiths Group and Savills directors buys shares

24th Mar 2026 14:13

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and Tuesday and not separately reported by Alliance News: Read More

GSK's lung cancer treatment secures "orphan drug" status in Japan

23rd Mar 2026 08:37

(Alliance News) - GSK PLC on Monday said Japanese health authorities had granted "orphan drug" status to its lung cancer treatment. Read More

LONDON BRIEFING: GSK gains Japan nod; Anglo to delist shares in Zurich

23rd Mar 2026 07:59

(Alliance News) - GSK makes regulatory progress in Japan for a cancer therapy, Anglo American moves to delist from the Swiss exchange as part of its restructuring, and Applied Nutrition reports strong interim growth while holding back on shareholder payouts. Read More

12345678910
FTSE 100 Latest
Value10,609.08
Change-58.55